{"brief_title": "Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)", "brief_summary": "The purpose of this study is to determine the efficacy and tolerability of an investigational drug for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy.", "condition": "Breast Neoplasms", "intervention_type": "Drug", "intervention_name": "MK0869, aprepitant / Duration of Treatment: 3 days", "criteria": "Inclusion Criteria: - Patient with a diagnosis of breast cancer requiring treatment with non-cisplatin moderately emetogenic chemotherapy. - Patient must have completed participation in the main study for this protocol. Exclusion Criteria: - Patient has a central nervous system malignancy. - Patient will receive radiation to the abdomen or pelvis.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00092196.xml"}